2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
April 24th, 2025
Version: 1
Memorial Sloan Kettering Cancer Center
systems biology
biorxiv

Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations

Ambaw, Y. A.Open in Google Scholar•Ljubenkov, P. A.Open in Google Scholar•Singh, S.Open in Google Scholar•Hamed, A.Open in Google Scholar•Boland, S.Open in Google Scholar•Boxer, A. L.Open in Google Scholar•Walther, T. C.Open in Google Scholar•Farese, R.Open in Google Scholar

Developing new treatment strategies for frontotemporal dementia (FTD) and other forms of neurodegeneration requires biomarkers to monitor disease progression. Dysregulated brain lipid metabolism, particularly sphingolipids enriched in the nervous system, is a key feature of neurodegeneration. However, plasma lipids have been investigated less for their potential as biomarkers than brain imaging and serum proteins. Here we examined the plasma lipidomes of a cohort of heterozygous carriers of gene variants associated with autosomal dominant familial FTD (including GRN, C9orf72, and MAPT loci), comparing them with aged-matched controls. In general, FTD subjects exhibited increases in plasma levels of specific species of gangliosides (GM3(d18:1_16:0), GM3(d18:1_18:0), and GM3(d18:1_24:1)) and ceramide (Cer(d18:1_23:0)) and selected polyunsaturated triacylglycerols (TG). Other species of ceramides (Cer(d18:0_22:0)), phosphatidylethanolamine (PE(18:0_24:0)), and sphingomyelin (SM(38:0)) were reduced in plasma of FTD subjects. Levels of glucosylsphingosine (GlcSph(d18:1)) were elevated specifically in GRN carriers, SM(34:1) was reduced in C9orf72 carriers, and TG(16:0_18:1_20:3)) were decreased in MAPT variant carriers. Notably, the ganglioside GM3(d18:1_16:0) was consistently elevated across all FTD genetic subtypes. Furthermore, the levels of these lipids correlated with disease severity in FTD patients. Our findings suggest that specific plasma lipid changes, notably several sphingolipids, may be useful biomarkers for FTD disease or progression.

Similar Papers

biorxiv
Fri Apr 25 2025
A modelling assessment for the impact of control measures on highly pathogenic avian influenza transmission in poultry in Great Britain
Since 2020, large-scale outbreaks of highly pathogenic avian influenza (HPAI) H5N1 in Great Britain have resulted in substantial poultry mortality and economic losses. Alongside the costs, the risk of circulation leading to a viral reassortment that causes zoonotic spillover raises additional concerns. However, the precise mechanisms driving transmission between poultry premises and the impact of ...
Davis, C. N.
•
Hill, E. M.
•
Jewell, C. P.
•
Rysava, K.
...•
Tildesley, M. J.
biorxiv
Fri Apr 25 2025
Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles
Resistance to targeted therapies is a significant clinical problem, but eliminating resistant cancer cells has proven difficult. One potential reason for this difficulty is heterogeneity in the resistant population: even genetically homogeneous cancer cell populations can give rise to a variety of resistant subtypes, each potentially with their own specific second-line drug vulnerabilities. Using ...
Busch, G. T.
•
Boe, R. H.
•
Li, J.
•
Gruener, R. F.
...•
Raj, A.
biorxiv
Thu Apr 24 2025
Integrated tumour-immune cell response modelling of Luminal A breast cancer details malignant signalling and ST3Gal1 inhibitor induced reversal
Aberrant O-glycosylation of mucin-type glycopeptide 1 (MUC1) is implicated in cancerous cellular processes involving the manipulation of immune response to favour tumour growth and metastasis. There is an unmet need for systems glycobiology models to probe the relationship between MUC1 O-glycosylation and immune cells within the tumour microenvironment. We expand on the sparsely understood MUC1 an...
Kaya, H. E.
•
Naidoo, K. J.
biorxiv
Wed Apr 23 2025
Time-series RNA-Seq and data-driven network inference unveil dynamics of cell activation, survival and crosstalk in Chronic Lymphocytic Leukaemia in vitro models
How do cancer cells respond to their environment, and what are the key regulators behind their behaviour? While immune cell reprogramming in the tumour microenvironment (TME) has been extensively studied, the dynamic regulatory changes within cancer cells in response to interactions with immune cells remain poorly understood. In Chronic Lymphocytic Leukaemia (CLL), this knowledge gap limits our ab...
Marku, M.
•
Chenel, H.
•
Bordenave, J.
•
Hurtado, M.
...•
Pancaldi, V.
biorxiv
Wed Apr 23 2025
Mixing features of transcription factors and genes enables accurate prediction of gene regulation relationships for unknown transcription factors
Identifying regulatory relationships between transcription factors (TFs) and genes is essential to understand diverse biological phenomena related to gene expression. Recently, deep learning-based models to predict TFs that bind to genes from nucleotide sequences of the target genes have been developed, yet these models are trained to predict known TFs only. In this study we developed a deep learn...
Okubo, R.
•
Morikura, T.
•
Hiki, Y.
•
Tokuoka, Y.
...•
Funahashi, A.
biorxiv
Wed Apr 23 2025
Parameter Estimation and Model Selection for the Quantitative Analysis of Oncolytic Virus Therapy in Zebrafish
Oncolytic virus therapy (OVT) is emerging as a potent alternative to conventional cancer treatments by employing engineered viruses that selectively infect and lyse tumor cells while sparing normal tissues. Although mathematical models have been developed to elucidate the dynamics of OVT and inform personalized therapies, they are often specific to certain organisms. Mathematical models tailored t...
Liu, Y.
•
Pathirana, D.
•
Hasenauer, J.
biorxiv
Wed Apr 23 2025
Ubiquitous systems drift in the evolution of development
Developmental systems drift (DSD) is a process where a phenotypic trait is conserved over evolutionary time, while the genetic basis for the trait changes. DSD has been identified in models with simpler genotype-phenotype maps (GPMs), however the extent of DSD in more complex GPMs, such as developmental systems, is debated. To investigate the occurrence of DSD in complex developmental GPMs, we con...
van der Jagt, P. L.
•
Oud, S.
•
Vroomans, R. M. A.
biorxiv
Tue Apr 22 2025
Spatial proteomics with 100+ markers with Highly Multiplexed MALDI-IHC
Highly multiplexed, antibody-based protein imaging of tissue has yielded many insights but does not yet allow the routine analysis of more than 50 markers simultaneously. By leveraging the ability of Matrix-Assisted Laser Desorption/Ionization (MALDI) imaging to resolve hundreds of m/z peaks without spectral overlap, MALDI-IHC with photocleavable mass-tag (PCMT)-labelled antibodies offers the poss...
Zhang, M.
•
Abbey, J. A.
•
Bost, P.
•
Usui, G.
...•
Bodenmiller, B.
biorxiv
Tue Apr 22 2025
Long-range massively parallel reporter assay reveals rules of distal enhancer-promoter interactions
Long-range activation is an essential property of enhancers, yet the features determining long-range enhancer activities have not been systematically investigated due to a lack of high-throughput methods to measure long-range enhancer activities efficiently. To address this gap, we present a long-range massively parallel reporter assay (long-range MPRA), an assay allowing the measurement of hundre...
Wu, Y.
•
Li, J.
•
Bartley-Dier, E. L.
•
Pitts, C.
•
Cohen, B. A.